Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2025 16:15 ET | Source: Bioventus, Inc.

Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference

DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief...
November 04, 2025 07:30 ET | Source: Bioventus, Inc.

Bioventus Reports Third Quarter Financial Results

Q3 reported revenue of $138.7 million was comparable to last year and organic* revenue advanced 8%Third quarter GAAP earnings of $0.05 per diluted share increased compared to the prior-year period...
October 28, 2025 07:00 ET | Source: Bioventus, Inc.

Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025

DURHAM, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
September 03, 2025 07:30 ET | Source: Bioventus, Inc.

Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President...
August 07, 2025 16:15 ET | Source: Bioventus, Inc.

Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference

DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief...
August 06, 2025 07:00 ET | Source: Bioventus, Inc.

Bioventus Reports Second Quarter Financial Results

Q2 reported revenue of $147.7 million declined 2.4%; Organic* revenue advanced 6.2%Second quarter diluted earnings per share was $0.11 compared to a diluted loss per share of $0.40 in the prior-year...
August 04, 2025 08:00 ET | Source: Bioventus, Inc.

Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity

DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has entered...
July 30, 2025 07:30 ET | Source: Bioventus, Inc.

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

DURHAM, N.C., July 30, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced today a significant milestone with the U.S. Food and Drug...
July 29, 2025 16:15 ET | Source: Bioventus, Inc.

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
May 06, 2025 07:30 ET | Source: Bioventus, Inc.

Bioventus Reports First Quarter Financial Results

Q1 reported revenue of $123.9 million declined 4.3%; Organic* revenue advanced 5.0%First quarter net loss was $0.04 per share compared to a loss of $0.08 in the prior-year periodNon-GAAP earnings* of...